Renal function and thromboprophylaxis in critically ill patients

about

Renal function and thromboprophylaxis in critically ill patients

Item

http://www.wikidata.org/entity/Q41959528

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Renal function and thromboprophylaxis in critically ill patients

@en

type

Item

label

Renal function and thromboprophylaxis in critically ill patients

@en

prefLabel

Renal function and thromboprophylaxis in critically ill patients

@en

P1476

Renal function and thromboprophylaxis in critically ill patients

@en

P2093

Anton G Saayman

http://www.w3.org/2001/XMLSchema#string

Christopher D Hingston

http://www.w3.org/2001/XMLSchema#string

Gareth M Scholey

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial.

Comparative pharmacokinetics of LMWHs.

Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin.

The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapies.

Glomerular hyperfiltration and albuminuria in critically ill patients.

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.

P2888

cc8985

P304

416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC8985

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matt P. Wise

P577

2010-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44625665

http://www.w3.org/2001/XMLSchema#string

P6179

1020974468

http://www.w3.org/2001/XMLSchema#string

P698

20497594

http://www.w3.org/2001/XMLSchema#string

P932

2911697

http://www.w3.org/2001/XMLSchema#string